Former NFL quarterback and 2026 Hall of Fame inductee highlights daily life for people living with severe food allergies and role preparedness ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

ARS as a commercial company. It was a year focused on building infrastructure, educating the market and learning as we introduce a new treatment into a well-established therapeutic category. Neffy is ...

ARS Pharmaceuticals (NASDAQ:SPRY) reported first-quarter 2026 revenue of $22.7 million as executives said the company is working to expand access, reduce prescribing friction and build momentum for ...

Neffy is a needle-free nasal spray approved by the FDA for severe allergic reactions, including anaphylaxis. The recommended dosage of Neffy depends on someone’s body weight in kilograms. It is ...

TORONTO, April 15, 2026 /CNW/ - ALK-Abello Pharmaceuticals Inc. Canada (ALK Canada) today announced that Health Canada has approved neffy ® 2 mg for the emergency treatment of allergic reactions ...

Storage guidelines for neffy now indicate the product remains usable after thawing and can withstand brief exposure to high temperatures of up to 122 degrees Fahrenheit. The Food and Drug ...

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients ...

The FDA’s Office of Prescription Drug Promotion (OPDP) has issued a pointed warning to ARS Pharmaceutical Operations, calling its direct-to-consumer television advertisement for Neffy (epinephrine ...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On January 2, Roth MKM reiterated its Buy rating on ARS Pharmaceuticals, Inc.

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...

Q: I heard there's a new nasal spray that can be used instead of an EpiPen. Is that true? A: Yes. The Food and Drug Administration recently approved Neffy, the first nasal spray form of epinephrine.